brain cancer

BETHESDA, Md., July 2, 2026 Northwest Biotherapeutics announced that its Chief Technical Officer, Dr. Marnix Bosch, will deliver a...

BALTIMORE, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of Health...

STAMFORD, Conn., June 24, 2026 Knoa Pharma LLC and the Global Coalition for Adaptive Research (GCAR) announced a significant...

BAAR, Switzerland | June 18, 2026 Novocure has announced topline results from its Phase 3 TRIDENT trial, which evaluated...

CALABASAS, Calif., June 16, 2026 NeOnc Technologies Holdings, Inc. announced that the Department of Health – Abu Dhabi (DOH)...

SEONGNAM and SEOUL, South Korea, June 15, 2026 Rznomics Inc., a clinical-stage biopharmaceutical company focused on RNA-based gene therapies,...

TEMPE, Ariz., May 30, 2026 GT Medical Technologies announced positive Phase 3 results from the randomized multicenter ROADS clinical...

SHANGHAI, China, May 29, 2026 Dizal has announced groundbreaking results from the global Phase 3 WU-KONG28 trial, demonstrating that...

BOSTON, Massachusetts, May 31, 2026 Servier has announced extended follow-up results from the pivotal Phase 3 INDIGO trial, demonstrating...

Edinburgh, UK | May 28, 2026 Clinical-stage oncology company Trogenix announced the first patient has been dosed in the...